vs
BayCom Corp（BCML）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
BayCom Corp的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.9M vs $19.6M），BayCom Corp净利率更高（26.5% vs -177.4%，领先203.9%），BayCom Corp同比增速更快（9.4% vs -11.5%），BayCom Corp自由现金流更多（$30.1M vs $-23.1M），过去两年BayCom Corp的营收复合增速更高（2.9% vs -12.2%）
BayCom Corp是总部位于美国的银行控股公司，旗下拥有海湾商业银行，主要服务北加州地区的中小微企业与零售客户，提供商业贷款、存款产品、个人银行、财富管理等多元金融服务，深耕本土社区金融市场。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BCML vs LAB — 直观对比
营收规模更大
BCML
是对方的1.3倍
$19.6M
营收增速更快
BCML
高出20.9%
-11.5%
净利率更高
BCML
高出203.9%
-177.4%
自由现金流更多
BCML
多$53.2M
$-23.1M
两年增速更快
BCML
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.9M | $19.6M |
| 净利润 | $6.9M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 36.6% | -168.5% |
| 净利率 | 26.5% | -177.4% |
| 营收同比 | 9.4% | -11.5% |
| 净利润同比 | 12.1% | -28.8% |
| 每股收益（稀释后） | $0.63 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCMLLAB
| Q4 25 | $25.9M | — | ||
| Q3 25 | $25.7M | $19.6M | ||
| Q2 25 | $24.7M | $21.8M | ||
| Q1 25 | $24.3M | $40.8M | ||
| Q4 24 | $23.7M | — | ||
| Q3 24 | $25.6M | $22.1M | ||
| Q2 24 | $23.8M | $22.5M | ||
| Q1 24 | $24.5M | $45.5M |
净利润BCMLLAB
| Q4 25 | $6.9M | — | ||
| Q3 25 | $5.0M | $-34.7M | ||
| Q2 25 | $6.4M | $-33.5M | ||
| Q1 25 | $5.7M | $-26.0M | ||
| Q4 24 | $6.1M | — | ||
| Q3 24 | $6.0M | $-26.9M | ||
| Q2 24 | $5.6M | $-45.7M | ||
| Q1 24 | $5.9M | $-32.2M |
毛利率BCMLLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率BCMLLAB
| Q4 25 | 36.6% | — | ||
| Q3 25 | 26.3% | -168.5% | ||
| Q2 25 | 35.3% | -118.1% | ||
| Q1 25 | 31.6% | -80.8% | ||
| Q4 24 | 34.2% | — | ||
| Q3 24 | 32.4% | -120.9% | ||
| Q2 24 | 31.9% | -134.5% | ||
| Q1 24 | 33.3% | -132.2% |
净利率BCMLLAB
| Q4 25 | 26.5% | — | ||
| Q3 25 | 19.5% | -177.4% | ||
| Q2 25 | 25.8% | -153.7% | ||
| Q1 25 | 23.4% | -63.8% | ||
| Q4 24 | 25.9% | — | ||
| Q3 24 | 23.5% | -122.0% | ||
| Q2 24 | 23.6% | -203.3% | ||
| Q1 24 | 24.0% | -70.6% |
每股收益（稀释后）BCMLLAB
| Q4 25 | $0.63 | — | ||
| Q3 25 | $0.46 | $-0.09 | ||
| Q2 25 | $0.58 | $-0.09 | ||
| Q1 25 | $0.51 | $-0.07 | ||
| Q4 24 | $0.55 | — | ||
| Q3 24 | $0.54 | $-0.07 | ||
| Q2 24 | $0.50 | $-0.12 | ||
| Q1 24 | $0.51 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $338.6M | $399.7M |
| 总资产 | $2.6B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCMLLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务BCMLLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益BCMLLAB
| Q4 25 | $338.6M | — | ||
| Q3 25 | $334.3M | $399.7M | ||
| Q2 25 | $330.6M | $424.5M | ||
| Q1 25 | $329.3M | $454.6M | ||
| Q4 24 | $324.4M | — | ||
| Q3 24 | $321.7M | $489.3M | ||
| Q2 24 | $315.3M | $510.3M | ||
| Q1 24 | $314.2M | $577.3M |
总资产BCMLLAB
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $539.6M | ||
| Q2 25 | $2.6B | $557.0M | ||
| Q1 25 | $2.6B | $579.6M | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.6B | $681.5M | ||
| Q2 24 | $2.6B | $708.7M | ||
| Q1 24 | $2.6B | $777.7M |
负债/权益比BCMLLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $30.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | 116.2% | -118.1% |
| 资本支出强度资本支出/营收 | 6.7% | 4.5% |
| 现金转化率经营现金流/净利润 | 4.64× | — |
| 过去12个月自由现金流最近4个季度 | $51.1M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BCMLLAB
| Q4 25 | $31.8M | — | ||
| Q3 25 | $7.3M | $-22.2M | ||
| Q2 25 | $6.4M | $-20.7M | ||
| Q1 25 | $9.3M | $-30.3M | ||
| Q4 24 | $30.4M | — | ||
| Q3 24 | $9.6M | $-27.9M | ||
| Q2 24 | $7.7M | $-39.0M | ||
| Q1 24 | $5.1M | $-62.5M |
自由现金流BCMLLAB
| Q4 25 | $30.1M | — | ||
| Q3 25 | $6.2M | $-23.1M | ||
| Q2 25 | $5.6M | $-22.6M | ||
| Q1 25 | $9.1M | $-35.3M | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $9.4M | $-30.1M | ||
| Q2 24 | $7.4M | $-41.0M | ||
| Q1 24 | $3.9M | $-63.3M |
自由现金流率BCMLLAB
| Q4 25 | 116.2% | — | ||
| Q3 25 | 24.3% | -118.1% | ||
| Q2 25 | 22.8% | -103.6% | ||
| Q1 25 | 37.6% | -86.6% | ||
| Q4 24 | 121.1% | — | ||
| Q3 24 | 36.6% | -136.4% | ||
| Q2 24 | 31.2% | -182.2% | ||
| Q1 24 | 16.1% | -138.9% |
资本支出强度BCMLLAB
| Q4 25 | 6.7% | — | ||
| Q3 25 | 4.3% | 4.5% | ||
| Q2 25 | 3.0% | 8.7% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 1.0% | 10.2% | ||
| Q2 24 | 1.0% | 8.6% | ||
| Q1 24 | 4.7% | 1.7% |
现金转化率BCMLLAB
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCML
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
